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Clinicopathological Significance of Expression of Tspan-1, Jab1 
and p27 in Human Hepatocellular Carcinoma
The aim of this study was to investigate the expression of Tspan-1, Jab1 and p27 in human 
hepatocellular carcinoma (HCC) and their clinicopathological significance. The expression 
of Tspan-1, Jab1 and p27 was detected in HCC tissues, the tissues around cancer (76 cases), 
and the normal tissues around the liver hemangiomas (10 cases). The overexpression of 
Tspan-1 and Jab1 was found in HCC tissues, positively correlated with clinical stage and 
negatively correlated with survival rate. The expression of p27 was found inversely linked to 
which of Tspan-1 and Jab1. In conclusion, the expression of Tspan-1, Jab1 and p27 is 
significantly associated with development of HCC. Overexpression of Tspan-1 and Jab1 
suggests poor prognosis but overexpression of p27 may expect good prognosis for patients 
with HCC.
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ORIGINAL ARTICLE
Oncology & Hematology
INTRODUCTION
Survival rate of the patients with hepatocellular earcinoma (HCC) 
was increased due to the advancement of diagnosis and treat-
ment, however, the total tendency has yet to be improved. Most 
cases were diagnosed at late stages. So far, the rate of surgical 
resection for HCC is around 20%; for most patients surgical treat-
ment was not indicated (1). A previous study reported that the 
five-year survival rate after radical resection was less than 50%, 
and the rate of metastasis was 61.5% (2). 
  Tetraspanins is a large family of ubiquitously expressed mem-
brane proteins. Several tetraspanins molecules such as CD9, 
CD82, CD63 and CD151 have been identified and implicated in 
the regulation of cell development, differentiation, proliferation, 
motility and tumor cell invasion (3-7). Tspan-1 (or NET-1, Gene 
ID: 10103) is a new member of the tetraspanins group. Sequence 
analysis of Tspan-1 revealed a structure typical for tetraspanins, 
with the presence of four transmembrane domains delimiting 
two extracellular regions as well as conserved amino acid resi-
dues (8). Tspan-1 was found to be overexpressed in some tu-
mors (9-14). Studies reported Tspan-1 expression may be asso-
ciated with tumor cells proliferation (9, 15). All of these reports 
suggest that Tspan-1 may play a critical role in the progression 
of tumor growth and metastasis in numerous human tumors, 
including HCC.
  P27 is a well known negative regulator of cell cycle progres-
sion. Jab1 directly binds to p27 and induces nuclear export and 
subsequent degradation (16). Some reports have shown that 
overexpression of Jab1 and low expression of p27 is associated 
with advanced tumor stage and poor prognosis in several hu-
man cancers (16-19), including HCC (20). 
  In the present study, we examined the expression of Tspan-1 
combined with Jab1, and p27 in specimens of 76 patients with 
HCC. The relationship between the expression of Tspan-1, Jab1 
and p27 with the clinicopathological factors and the prognosis 
of HCC patients were explored.
MATERIALS AND METHODS
Clinical data of the patients
Seventy-six specimens in this study were obtained from the pa-
tients with HCC in our hospital undergoing surgical operations 
of the liver during 1998-2004. The number patients was 76 cases 
(male 60, female 16) and mean age was 58 yr old (from 35 to 79). 
Histologically 10 cases were well differentiated, 42 cases were 
intermediate differentiated, and 24 cases were poorly differen-
tiated. Of them 23 cases had portal vein tumor thrombus and 
distant dissection. Normal control tissues of the liver were tak-Chen L, et al.  •  Tspan-1, Jab1 and p27 Expression in Human Hepatocellular Carcinoma
http://jkms.org   1439 DOI: 10.3346/jkms.2010.25.10.1438
en from ten patients operated for hemangioma. The follow-up 
period of the patients exceeded 60 months. Informed consent 
was obtained before any specimens were taken. The study pro-
tocol was approved by the Ethics Committee of the affiliated 
hospital of Nantong University (NTU090024).
Antibodies used in immunohistochemisty
The antibodies used for immunohistochemistry in this study 
were: Tspan-1 rabbit anti-human polyclonal antibody (1:100; 
devised by the author and prepared under the cooperation of 
the American San Francisco Gene Biological Company, San 
Francisco, CA, USA), mouse monoclonal antibody against hu-
man Jab1 (611618, 1:50;BD Biosciences PharMingen, San Diego, 
CA, USA), rabbit anti-human p27 polyclonal antibody (C-19, 
1:50; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), 
HRP-goat anti-rabbit IgG (1:200; Sigma-Aldrich, St. Louis, MO, 
USA), HRP-goat anti-mouse IgG (1:200; Sigma-Aldrich, St. Lou-
is, MO, USA).
Immunohistochemical examination of expression of 
Tspan-1, Jab1 and p27
Two-step immunohistochemical method was performed on 
formalin-fixed, paraffin-embedded 5-μm sections from all pa-
tients to detect the expression of Tspan-1, Jab1 and p27 in HCC. 
Five consecutive slides were prepared from each tissue. The 
slides were deparaffinized by dimethyl benzene, dehydrated by 
gradient ethanol. For antigen retrieval, they were heated at 95°C 
for 10 min in sodium citrate buffer (10 mM sodium-citrate mono-
hydrate, pH 6.0). Slides were allowed to cool for 20 min at room 
temperature, incubated in 0.3% H2O2 at room temperature for 
15 min to inhibit endogenous peroxidase, and then incubated 
with primary antibodies overnight at 4°C. Two-step reagent kit 
(HRP- anti-mouse/rabbit IgG) was then applied to detect the 
immunoreactivity. Slides were stained by DAB, and counter-
stained by hematoxylin. Rabbit IgG was used to replace the pri-
mary antibody as control staining. Gastric cancer tissue was used 
as positive control.
  For microscopy, five random high-magnification fields (×400) 
were selected from each slide to count 1,500 tumor cells. Per-
centage of positive cells was calculated and recorded as Label 
Index (LI=% of positive cells). The mean value of LI of Tspan-1, 
Jab1 and p27 (0.70, 0.69 and 0.26, respectively) in HCC tissues 
was used to define the over and low expression according to a 
previous study by other author (21).
Statistical analysis
The data of the expression of the proteins are presented as means 
±SD. Spearman test was applied to detect the correlation of among 
Tspan-1, Jab1 and p27 expression. Fisher’s exact test was used 
to compare the expression of all proteins as groups (positive vs. 
negative) with various clinicopathological parameters. Survival 
analysis was undertaken using Kaplan-Meier method and group 
differences in survival time were investigated by log-rank test. 
The multiple factor survival analysis was evaluated using Cox’s 
proportional hazards model. P values less than 0.05 was con-
sidered statistically significant. SPSS for Windows (version 13.0, 
SPSS Inc., Chicago, IL, USA) was used for all statistical analyses.
RESULTS
Expression of Tspan-1, Jab1 and p27 in HCC 
We studied the expression of Tspan-1, Jab1 and p27 in HCC tis-
sues (76 cases), the tissues around HCC (76 cases), and the nor-
mal tissues around the liver hemangiomas (10 cases). The ex-
pression of Tspan-1 in HCC cells varies from cytoplasm to mem-
brane, or mixed. Jab1 and p27 were mainly expressed in nucle-
us, but also in cytoplasm (Fig. 1). The difference of expression 
levels of these molecules in the three types of tissues was shown 
in Table 1. Statistical analysis revealed that the expression of 
Tspan-1, Jab1 was significantly higher in HCC than in the tissues 
around cancer or normal control (P<0.05). And the expression 
of p27 in HCC was remarkably lower than in the other two tis-
sues (P<0.05). 
Correlation of the expression of Tspan-1, Jab1 and p27  
in HCC
The correlation of expressions of Tspan-1, Jab1 and p27 in HCC 
was examined by Spearman test. Statistical analysis showed 
Fig. 1. Immunostaining of Tspan-1, Jab1 and p27 in HCC. (A) Tspan-1 expression, indicated by yellowish granules, varies from cytoplasm to membrane, or mixed. (B) Jab1 and 
(C) p27 expression, indicated by brownish yellow granules, are mainly in nuclear, but also can be found in cytoplasm. Magnification ×200.
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that Tspan-1 was positively associated with Jab1 (r=0.6045, P< 
0.001), but inversely correlated with p27 (r=-0.6971, P<0.001).  
It also indicated that Jab1 was inversely associated with p27 (r= 
-0.7089, P<0.001). 
Table 1. Expression of Tspan-1, Jab1 and p27 in HCC tissues, the tissues around cancer and the normal tissues (%)
Proteins
The normal tissues (A) Tissues around cancer(B) HCC tissues (C)
LI P
1 LI P
2 LI P
3
Tspan-1 10.68±1.76 <0.001 36.87±9.77 <0.05 69.65±14.06 <0.001
Jab1 34.36±8.16 <0.001 38.72±9.56 >0.05 68.85±12.10 <0.001
p27   73.58±10.44 <0.001 76.20±8.20 >0.05 26.50±13.30 <0.001
P
1, A group vs. C; P
2, A group vs. B; P
3, B group vs. C; LI, % of positive cells. 
Table 2. Correlation of the expression of Tspan-1, Jab1 and p27 with clinicopathological factors in HCC
Clinical parameter Samples
Tspan-1
P
Jab1
P
p27
P
Low ≤0.70 Over >0.70 Low ≤0.69 Over  >0.69 Low ≤0.26 Over >0.26
Age (yr)
   ≤45
   >45
21
55
  8
26
13
29 0.472
  7
26
14
29 0.273
13
31
  8
24 0.662
Gender
   Male
   Female
60
16
29
  5
31
11 0.222
27
  6
33
10 0.591
34
10
26
  6 0.675
Differentiation
   Well
   Intermediate
   Poor
10
42
24
  6
24
  4
  4
18
20 0.003
  8
20
  5
  2
22
19 0.005
  
2
20
22
  8
22
  2 0
Metastasis
   N1-3
   N0
23
53
  7
32
16
21 0.016
  5
28
18
25 0.012
20
24
  3
29 0.001
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Fig. 2. Kapalan-Meier survival curves of patients with HCC. (A) Overall survival rate is 
significantly lower in patients with Tspan-1 overexpression. (B) Overall survival rate is 
significantly lower in patients with Jab1 overexpression. (C) Overall survival rate is 
significantly higher in patients with p27 overexpression.Chen L, et al.  •  Tspan-1, Jab1 and p27 Expression in Human Hepatocellular Carcinoma
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Correlation of the expression of Tspan-1, Jab1 and p27 
with clinicopathological factors in HCC
The overexpression of Tspan-1, Jab1 was negatively related to 
cancer cell differentiation and tumor metastasis (P<0.05). The 
overexpression of p27 was significantly and positively related to 
cancer differentiation and tumor metastasis (P<0.05). There was 
no significantly difference between low expression and over ex-
pression of the three proteins in terms of age and gender (P> 
0.05) (Table 2).
Correlation of the expression of Tspan-1, Jab1 and p27 
with the patients’ survival 
Survival analysis was done in 76 patients in whom follow-up data 
and results for the expression of Tspan-1, Jab1 and p27 were 
available. By using the Kaplan-Meier analysis, the patients with 
Tspan-1 and Jab1 overexprssion are significantly associated with 
short overall survival (P<0.05) (Fig. 2A, B). Statistical analysis 
also indicated that the survival rate of the p27 overexpression 
group was significantly higher than that of the low expression 
group (P<0.05) (Fig. 2 C). Multivariate analysis using the Cox’s 
proportional hazards model showed that Tspan-1, Jab1 and p27 
protein are independent prognostic indicators for patients’ over-
all survival (P=0.018, P=0.012, P=0.002, respectively).
DISCUSSION
Tspan-1, a new member of the tetraspanins group, is a recently 
discovered tumor-related gene. Some reports had indicated that 
Tspan-1 can stimulate proliferation, invasion and motility of tu-
mor cells (9, 22). In the present study, we found that the expres-
sion of Tspan-1 in HCC tissues was significantly higher than the 
tissues around cancer or the normal tissues. There is also a strong 
positive correlation between the level of Tspan-1 expression and 
degree of HCC cell differentiation and clinical stages. Further-
more, we found that Tspan-1 was an independent factor affect-
ing prognosis of HCC. The over expression of Tspan-1 increased 
the risk of death. Five-year survival rate in patients with over-
expression of Tspan-1 was significantly lower than those pa-
tients with low expression of Tspan-1.
  In the present study, we found that Jab1 and p27 expression 
were inversely correlated, and significantly associated with ma-
lignancy, prognosis and survival rate in patients with HCC. Sim-
ilar to our work, other reports indicated that Jab1 overexpres-
sion was significantly associated with poor prognosis of patients 
with tumors such as ovarian tumor, lung cancer and breast can-
cer, and was inversely associated with p27 (23-25). It has been 
known that p27 regulate cell proliferation as Cdk inhibitor by 
inhibiting cell cycle progression from G1 to S phase in a dose-
dependent fashion. Jab1 can accelerate the degradation of p27 
by translocating p27 from nucleus to cytoplasm where degra-
dation occur (26).
  The expression of Tspan-1 in cancer cells displayed cytoplas-
mic or membranous patterns, which showed the distribution 
and functional sites of the Tspan-1 molecule in cells. The mole-
cule may accept extracellular signals when located on the mem-
brane and carry out functions in the cytoplasm, like other tet-
raspanins such as CD9, CD82 and CD63 (27, 28). Leyden et al. 
reported that siRNA-mediated downregulation of Tspan-1 in-
hibited the proliferation of gastric cancer cells in vitro by inhib-
iting cell cycle progression from G1 to S phase (9). In our study, 
we found that Tspan-1 was positively associated with Jab1, and 
inversely correlated with p27. It has been known that p27 was 
degraded specifically in the cytoplasm by the ubiquitin (Ub)-
proteasome system (29). So we pursued the question whether 
Tspan-1 interacted with some other proteins to affect the ubiq-
uitin (Ub)-proteasome system degrading p27 or interacted with 
Jab1 to accelerate the transportion of p27 from nucleus to cyto-
plasm, and then led to accelerate the tumor cells proliferation. 
  In summary, the expression of Tspan-1, Jab1 and p27 in HCC 
is involved in cancer cell behavior including proliferation, dif-
ferentiation, metastasis, and clinical stage. Overexpression of 
Tspan-1 and Jab1 suggested poor prognosis but of p27 may ex-
pect good prognosis for patients with HCC.
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